Data / Form D filings / BIOSCALE INC
BIOSCALE INC: Form D filings
BIOSCALE INC, a biotechnology company in Lexington, MA, filed 5 Form D notices with the SEC between 2010 and 2013. The latest, on July 8, 2013, reports $18.8 million sold of a $38.3 million offering to 69 investors.
Find out what BIOSCALE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4 MAGUIRE ROAD, Lexington, MA, 02421
- Phone
- (781) 430-6800
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1270091
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2013 | New notice | $38,341,397 | $18,838,559 | $19,502,838 | 69 | Jun 21, 2013 | sec.gov |
| Mar 11, 2013 | New notice | $5,097,733 | $1,062,028 | $4,035,705 | 25 | Jan 25, 2013 | sec.gov |
| Feb 21, 2013 | Amendment | $10,690,400 | $3,827,004 | $6,863,396 | 62 | Oct 5, 2012 | sec.gov |
| Mar 6, 2012 | New notice | $10,522,100 | $5,261,050 | $5,261,050 | 37 | Feb 22, 2012 | sec.gov |
| Jun 11, 2010 | New notice | $25,000,000 | $15,672,158 | $9,327,842 | 42 | May 28, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brett Masters | Executive Officer | |
| Somu Subramaniam | Director | |
| Isaac Cheng | Director | |
| Bard Geesaman | Director | |
| Dr. Martin Latterich | Executive Officer | |
| Mark Lundstrom | Executive Officer, Director | |
| Chip Leveille | Executive Officer | |
| Edward Crawley | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
Every Form D from the week of Jul 8, 2013 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BIOSCALE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.